Resveratrol enhances the chemotherapeutic response and reverses the stemness induced by gemcitabine in pancreatic cancer cells via targeting SREBP1

OBJECTIVES: Gemcitabine is a standard treatment for advanced pancreatic cancer patients but can cause chemoresistance during treatment. The chemoresistant cells have features of cancer stem cells (CSCs). Resveratrol has been reported to overcome the resistance induced by gemcitabine. However, the me...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Prolif
Main Authors: Zhou, Cancan, Qian, Weikun, Ma, Jiguang, Cheng, Liang, Jiang, Zhengdong, Yan, Bin, Li, Jie, Duan, Wanxing, Sun, Liankang, Cao, Junyu, Wang, Fengfei, Wu, Erxi, Wu, Zheng, Ma, Qingyong, Li, Xuqi
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6430460/
https://ncbi.nlm.nih.gov/pubmed/30341797
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cpr.12514
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados